Latest Blogs

Women in Oncology
Sep 19, 2018
Motherhood on the Road: When Childcare and Professional Development Conflict
As an academic physician, Dr. Krisha Howell attends conferences for professional growth and networking; as a parent, one of her gating considerations is the availablity of childcare. 
Monica M. Bertagnolli, MD
Sep 18, 2018
Gain Policy Expertise, Leadership Experience in ASCO’s Health Policy Leadership Development Program
This program’s application period closes on September 25, so apply today if you are interested in being a leader in shaping cancer policy.
International Perspectives
Sep 17, 2018
World Cancer Research Day: The Future of Cancer Research Depends on All of Us
ASCO's nearly 45,000 members practice in more than 150 countries, and continued progress against cancer will require every one of us, writes ASCO CMO Dr. Richard L. Schilsky.
Clifford A. Hudis, MD, FACP, FASCO
Sep 11, 2018
Concerns With 2019 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule
We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Jun 22, 2018
So Busy and So Worthwhile: ASCO and the AMA House of Delegates
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as a modifiable risk for cancer, and more.
Nov 20, 2017
Aloha from the ASCO AMA House of Delegates
The ASCO delegation was very busy at the American Medical Association House of Delegates recent interim meeting.
Jun 29, 2017
AMA House of Delegates: These are Impactful Times
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
Become Engaged, Stay Engaged: More Important Than Ever
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Jun 22, 2016
So Much Done, So Much More to Do: AMA House of Delegates Report
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
AMA House of Delegates: A Glimpse into the Future
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.

Pages